Jan 12 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd
* Says Shantou-based pharmaceutical unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration and the valid period is until Jan. 3, 2023
* Certificate issued to unitâ€™s products including troche, hard capsule and granula
Source text in Chinese: goo.gl/zfLxSe
Further company coverage: (Beijing Headline News)
 